# Nayan Therapeutics, Inc. — Form D

Nayan Therapeutics, Inc. of MEDFIELD, MA, a company, filed a Form D exempt-offering notice with the SEC on 2019-02-13. The offering totals $25.0M, of which $3.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2019-02-13
- Form: D
- Accession: 0001767190-19-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $25.0M
- Amount sold: $3.0M
- Remaining: $22.0M
- Minimum investment: $382K
- Investors: 3
- Date of first sale: 2019-02-04
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-332794

## Issuer

- Name: Nayan Therapeutics, Inc.
- CIK: 0001767190
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 266 MAIN STREET BUILDING 2 SUITE 11, MEDFIELD, MA, 02052
- Phone: 6177782572

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| MILIND DESHPANDE | Director | WALTHAM, MA |
| Robert Millman | Director | MEDFIELD, MA |
| Joshua Resnick | Director | New York, NY |
| MILIND DESHPANDE | Executive Officer | WALTHAM, MA |
| David Neafus | Executive Officer | Walpole, MA |
| Robert Millman | Promoter | MEDFIELD, MA |

## More

- [CIK 1767190 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1767190&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001767190-19-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.